IP Library Granted Patent US 11,903,986
Granted Patent B2
US 11,903,986 · App. 15/680,998 · Granted Feb 20, 2024

Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye

Inventors: Scott Whitcup (Laguna Hills, CA); Orest Olejnik (Reno, NV); Michael Garst (Newport Beach, CA)
Assignee: Akrivista LLC
A61K36/185A61K9/0048A61K9/08A61K9/107A61K9/1075A61K31/045A61K31/7048A61K33/00A61K33/14A61K33/20A61K33/22A61K36/235A61K36/534A61K36/54A61K36/61A61K36/752A61K45/06A61K47/10A61K47/183A61K47/26A61K47/32A61K47/38G01N33/487G01N33/6827G01N33/6893G01N33/84G01N2800/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,903,986
App. No.
15/680,998
Granted
Feb 20, 2024
Kind
B2
Abstract

In preferred the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil.

Claims (20)

1. A composition for applying to the eye or eyelid of a human comprising:

0.05% (w/v) to less than about 0.3% (w/v), inclusive, of a plant-based oil consisting of avocado oil; and

the remaining about 99.95% to about 99.7%, inclusive, of water and at least one non-oil component selected from the group consisting of: an emulsifier component, a surfactant component, a tonicity component, a polyelectrolyte component, an emulsion stability component, a viscosity-inducing component, a demulcent component, an anti-oxidant component, a pH adjustment component, a buffer component, and a preservative component.

2. The composition of claim 1 , wherein the at least one component comprises a tonicity component, a viscosity enhancing agent, and a surfactant.

3. The composition of claim 1 , wherein the at least one component comprises a viscosity enhancing agent.

4. The composition of claim 3 , wherein the viscosity enhancing agent comprises methylcellulose (MC), carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), hydroxyethyl cellulose (HEC), hyaluronic acid salts, or combinations thereof.

5. The composition of claim 1 , having a viscosity of from greater than one 1.0 centipoise (cP) to about 250 cP.

6. A composition for applying to the eye or eyelid of a human consisting of:

water;

0.05% (w/v) to 0.3% (w/v), avocado oil; and

at least one non-oil component selected from the group consisting of: an emulsifier component, a surfactant component, a tonicity component, a polyelectrolyte component, an emulsion stability component, a viscosity-inducing component, a demulcent component, an anti-oxidant component, a pH adjustment component, a buffer component, a preservative component, an anti-inflammatory drug, a biocidal agent, and a protein biologic.

7. The composition of claim 6 , wherein the at least one component comprises a tonicity component, a viscosity enhancing agent, and a surfactant.

8. The composition of claim 6 , wherein the at least one component comprises a viscosity enhancing agent.

9. The composition of claim 8 , wherein the viscosity enhancing agent comprises methylcellulose (MC), carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), hydroxyethyl cellulose (HEC), hyaluronic acid salts, or combinations thereof.

10. The composition of claim 6 , having a viscosity of from greater than one 1.0 centipoise (cP) to about 250 cP.

11. The composition of claim 6 , wherein the avocado oil is present at a concentration of from 0.05% (w/v) to 0.1% (w/v), inclusive.

12. The composition of claim 6 , wherein the composition is in the form of an artificial tear.

13. The composition of claim 6 , further comprising a biocidal agent.

14. The composition of claim 1 , wherein the composition is in the form of an artificial tear.

15. The composition of claim 1 , further comprising a biocidal agent.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME AND ADDRESS PREVIOUSLY RECORDED ON REEL 044700 FRAME 0593. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 9, 2024
From: WHITCUP, SCOTT; OLEJNIK, OREST; GARST, MICHAEL
To: AKRIVISTA LLC
Reel/Frame 066242/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: WHITCUP, SCOTT; OLEJNIK, OREST; GARST, MICHAEL
To: AKRIVISTA, LLC
Reel/Frame 044700/0593 →
Continuity (3)
Provisional Application 62377291 · Aug 19, 2016
Provisional Application 62448695 · Jan 20, 2017
Related Publication 20180050074A1 · Feb 22, 2018
Cited By (1)
US 12,220,439